Nancy enjoys painting seascapes and portraits, and prefers working in pastels. This artwork is a painting of her son at age 2. Nancy’s work has appeared in several juried shows and galleries in Connecticut and Rhode Island. Her work was featured in an exclusive exhibit at the Groton Public Library in 1998.
Jennifer worked in photography for many years and then turned to creating artwork using various media. Her artwork has been exhibited in numerous shows in Colorado and Nebraska, and she has works in private collections.
Amber created this artwork at age 15. She graduated from Soldotna High School on Alaska’s Kenai Peninsula. Amber is a former MDA State Goodwill Ambassador, and she received the 1994 MDA Personal Achievement Award for Alaska.
I've lived with CMT since my early 20s — more than half my life. The disease has progressed slowly over the years, mostly affecting my lower legs and hands, so that now I use a manual wheelchair part time.
A clinical trial is a test in humans of an experimental medication or therapy. Clinical trials are experiments, not treatments, and participation requires careful consideration.
Although it's possible to benefit from participating in a clinical trial, it's also possible that no benefit — or even harm — may occur. Keep your MDA clinic doctor informed about any clinical trial participation. (Note that MDA has no ability to influence who is chosen to participate in a clinical trial.)
In 1991, the genetic causes of Charcot-Marie-Tooth disease (CMT) were completely unknown. By a decade later, MDA-funded scientists had helped identify 10 CMT-linked genes and found evidence for several others. (There are now thought to be more than 30 genes in which flaws can cause CMT.) This accomplishment has led to genetic testing for many types of CMT, which has greatly improved diagnosis.
Of equal importance, the ongoing hunt for CMT genes has given insights into treatments that might be used to stop or reverse the disorder.